✦ LIBER ✦

Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents

✍ Scribed by Michael H. Davidson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurement of plasma 5-hydroxyindoleace

✍ Philip Kestell; Liangli Zhao; Michael B Jameson; Michael R.L Stratford; Lisa K F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Angiographic severity of coronary narrow

✍ Akihiro Nakagomi; David S. Celermajer; Thomas Lumley; S.Ben Freedman 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 478 KB

Challenges associated with evaluating th

✍ Maurie Markman 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 112 KB

Surrogate markers of clinical relevance

✍ Lasagna, L.; Allard, S.; Sainati, S.; Lavoisy, J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 272 KB

THE DEVELOPMENT AND CLINICAL UTILITY OF

✍ Rowinsky, MD, Eric K. 📂 Article 📅 1997 🏛 Annual Reviews 🌐 English ⚖ 134 KB

The Clinical Development of Molecularly

✍ Ozlem U. Ataman; Sally J. Sambrook; Chris Wilks; Andrew Lloyd; Amanda E. Taylor; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 642 KB